Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer

Yue Yuan, Zhiliang Wei, Chengyan Chu, Jia Zhang, Xiaolei Song, Piotr Walczak, Jeff W.M. Bulte

Research output: Contribution to journalArticle

Abstract

The healthy prostate contains the highest concentration of mobile zinc in the body. As this level decreases dramatically during the initial development of prostate cancer, in vivo detection of prostate zinc content may be applied for diagnosis of prostate cancer. Using 19F ion chemical exchange saturation transfer magnetic resonance imaging (iCEST MRI) and TF-BAPTA as a fluorinated Zn-binding probe with micromolar sensitivity, we show that iCEST MRI is able to differentiate between normal and malignant prostate cells with a 10-fold difference in contrast following glucose-stimulated zinc secretion in vitro. The iCEST signal decreased in normal prostate cells upon downregulation of the ZIP1 zinc transporter. In vivo, using an orthotopic prostate cancer mouse model and a transgenic adenocarcinoma of the mouse prostate (TRAMP) model, a gradual decrease of >300 % in iCEST contrast following the transition of normal prostate epithelial cells to cancer cells was detected.

Original languageEnglish (US)
Pages (from-to)15512-15517
Number of pages6
JournalAngewandte Chemie - International Edition
Volume58
Issue number43
DOIs
StatePublished - Oct 21 2019

Fingerprint

Biomarkers
Magnetic resonance
Zinc
Ion exchange
Ions
Imaging techniques
Cells
Glucose

Keywords

  • imaging agents
  • MRI
  • prostate cancer
  • zinc

ASJC Scopus subject areas

  • Catalysis
  • Chemistry(all)

Cite this

Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer. / Yuan, Yue; Wei, Zhiliang; Chu, Chengyan; Zhang, Jia; Song, Xiaolei; Walczak, Piotr; Bulte, Jeff W.M.

In: Angewandte Chemie - International Edition, Vol. 58, No. 43, 21.10.2019, p. 15512-15517.

Research output: Contribution to journalArticle

@article{753bab8830544fdb9653984cae8e1c85,
title = "Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer",
abstract = "The healthy prostate contains the highest concentration of mobile zinc in the body. As this level decreases dramatically during the initial development of prostate cancer, in vivo detection of prostate zinc content may be applied for diagnosis of prostate cancer. Using 19F ion chemical exchange saturation transfer magnetic resonance imaging (iCEST MRI) and TF-BAPTA as a fluorinated Zn-binding probe with micromolar sensitivity, we show that iCEST MRI is able to differentiate between normal and malignant prostate cells with a 10-fold difference in contrast following glucose-stimulated zinc secretion in vitro. The iCEST signal decreased in normal prostate cells upon downregulation of the ZIP1 zinc transporter. In vivo, using an orthotopic prostate cancer mouse model and a transgenic adenocarcinoma of the mouse prostate (TRAMP) model, a gradual decrease of >300 {\%} in iCEST contrast following the transition of normal prostate epithelial cells to cancer cells was detected.",
keywords = "imaging agents, MRI, prostate cancer, zinc",
author = "Yue Yuan and Zhiliang Wei and Chengyan Chu and Jia Zhang and Xiaolei Song and Piotr Walczak and Bulte, {Jeff W.M.}",
year = "2019",
month = "10",
day = "21",
doi = "10.1002/anie.201909429",
language = "English (US)",
volume = "58",
pages = "15512--15517",
journal = "Angewandte Chemie - International Edition",
issn = "1433-7851",
publisher = "John Wiley and Sons Ltd",
number = "43",

}

TY - JOUR

T1 - Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer

AU - Yuan, Yue

AU - Wei, Zhiliang

AU - Chu, Chengyan

AU - Zhang, Jia

AU - Song, Xiaolei

AU - Walczak, Piotr

AU - Bulte, Jeff W.M.

PY - 2019/10/21

Y1 - 2019/10/21

N2 - The healthy prostate contains the highest concentration of mobile zinc in the body. As this level decreases dramatically during the initial development of prostate cancer, in vivo detection of prostate zinc content may be applied for diagnosis of prostate cancer. Using 19F ion chemical exchange saturation transfer magnetic resonance imaging (iCEST MRI) and TF-BAPTA as a fluorinated Zn-binding probe with micromolar sensitivity, we show that iCEST MRI is able to differentiate between normal and malignant prostate cells with a 10-fold difference in contrast following glucose-stimulated zinc secretion in vitro. The iCEST signal decreased in normal prostate cells upon downregulation of the ZIP1 zinc transporter. In vivo, using an orthotopic prostate cancer mouse model and a transgenic adenocarcinoma of the mouse prostate (TRAMP) model, a gradual decrease of >300 % in iCEST contrast following the transition of normal prostate epithelial cells to cancer cells was detected.

AB - The healthy prostate contains the highest concentration of mobile zinc in the body. As this level decreases dramatically during the initial development of prostate cancer, in vivo detection of prostate zinc content may be applied for diagnosis of prostate cancer. Using 19F ion chemical exchange saturation transfer magnetic resonance imaging (iCEST MRI) and TF-BAPTA as a fluorinated Zn-binding probe with micromolar sensitivity, we show that iCEST MRI is able to differentiate between normal and malignant prostate cells with a 10-fold difference in contrast following glucose-stimulated zinc secretion in vitro. The iCEST signal decreased in normal prostate cells upon downregulation of the ZIP1 zinc transporter. In vivo, using an orthotopic prostate cancer mouse model and a transgenic adenocarcinoma of the mouse prostate (TRAMP) model, a gradual decrease of >300 % in iCEST contrast following the transition of normal prostate epithelial cells to cancer cells was detected.

KW - imaging agents

KW - MRI

KW - prostate cancer

KW - zinc

UR - http://www.scopus.com/inward/record.url?scp=85073184635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073184635&partnerID=8YFLogxK

U2 - 10.1002/anie.201909429

DO - 10.1002/anie.201909429

M3 - Article

C2 - 31430007

AN - SCOPUS:85073184635

VL - 58

SP - 15512

EP - 15517

JO - Angewandte Chemie - International Edition

JF - Angewandte Chemie - International Edition

SN - 1433-7851

IS - 43

ER -